Dynamic Hydrogel‐Mediated Co‐Delivery of Clotrimazole and Nifuratel for Safe and Effective In Vivo Cervical Cancer Treatment
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-11 · 114 (11)
DOI: 10.1002/jbm.b.70172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 01.11.2026. Verfasst von Monika Gosecka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Lodz, Poland. Hauptthemen laut MEDLINE: Clotrimazole, Uterine Cervical Neoplasms, Hydrogels, Drug Carriers. Die Arbeit nennt 43 Literaturangaben. Gefördert von: FENG.
Abstract (Originalsprache)
Systemic combination chemotherapy for cervical cancer is often limited by poor drug solubility and high toxicity. Over the past decade, there has been growing interest in local therapy using hydrogel‐based drug carriers that remain at the site of the lesion, thereby reducing side effects. However, to date, research has been limited mainly to in vitro studies. In this study, we demonstrate the use of dynamic hydrogels to ensure effective delivery of water‐insoluble drugs for in vivo anti‐cervical cancer therapy in a mouse model. The main structural component of the hydrogel was a non‐linear poly(benzyl glycidyl ether)‐poly(glyceryl glycerol ether) copolyether, which increases the solubility of the poorly water‐soluble clotrimazole and nifuratel and enables reversible cross‐linking, confering injectability and self‐healing behavior to the hydrogel. Two‐dose intratumoral implementation of hydrogel formulations resulted in a superior effect in the reduction of the tumor volume by > 90% within a 14‐day therapy. Unexpectedly, 50% of the mice with induced tumors were completely cured with a hydrogel constructed of copolyethers, whose molar ratio of constitutional repeating units of GGE to BGE was equal to 2:1. The drug loading of both drugs can be a key parameter crucial for the achievement of the superior efficacy of this formulation, making it a highly therapeutic delivery system. The use of copolyethers enhanced controlled drug delivery, as evidenced by a statistically significant reduction in tumor volume ( p < 0.001) compared to the efficacy of pure drugs (> 0.05). Furthermore, copolyether‐based formulations provide a safer therapeutic alternative to pure drugs. This was confirmed by blood biochemical analyses, which showed no increase in LDH or CRP levels, and by histopathological evaluations of mouse livers, which demonstrated that, unlike pure clotrimazole, the formulations do not induce liver damage. The high yield point detected for hydrogel and the strong mucosal adhesion of the synthesized hydrogels up to 18.7 kPa allow the formulation to remain at the target site. Surprisingly, we observed that incorporating clotrimazole into the hydrogel significantly increased mucosal adhesion strength. Permeability investigations performed on ex vivo porcine vaginal mucosa showed a sustained permeation reaching 40% and 25% of permeated nifuratel and clotrimazole, respectively. The presented dual drug‐loaded dynamic hydrogels are highly promising for clinical use in cervical cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Lodz, Poland.
- Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
- Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
- NanoBiomedical Centre, Adam Mickiewicz University, Poznan, Poland.
ORCID-Profile: Monika Gosecka, Malgorzata Urbaniak, Ewelina Wielgus, Renata Gruszka, Monika Marcinkowska, Barbara Klajnert-Maculewicz, Anna Janaszewska
Förderung
- FENG
Zitieren
APA
Gosecka, M., Gosecki, M., Urbaniak, M., Wielgus, E., Gruszka, R., Marcinkowska, M., Jancelewicz, M., Klajnert-Maculewicz, B., & Janaszewska, A. (2026). Dynamic Hydrogel‐Mediated Co‐Delivery of Clotrimazole and Nifuratel for Safe and Effective In Vivo Cervical Cancer Treatment. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(11). https://doi.org/10.1002/jbm.b.70172
Vancouver
Gosecka M, Gosecki M, Urbaniak M, Wielgus E, Gruszka R, Marcinkowska M, et al. Dynamic Hydrogel‐Mediated Co‐Delivery of Clotrimazole and Nifuratel for Safe and Effective In Vivo Cervical Cancer Treatment. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(11). doi:10.1002/jbm.b.70172
BibTeX
@article{Gosecka2026,
author = {Gosecka, Monika and Gosecki, Mateusz and Urbaniak, Malgorzata and Wielgus, Ewelina and Gruszka, Renata and Marcinkowska, Monika and Jancelewicz, Mariusz and Klajnert-Maculewicz, Barbara and Janaszewska, Anna},
title = {Dynamic Hydrogel‐Mediated Co‐Delivery of Clotrimazole and Nifuratel for Safe and Effective In Vivo Cervical Cancer Treatment},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2026},
volume = {114},
number = {11},
doi = {10.1002/jbm.b.70172}
}
EUVIMED